Intelligent spectrophotometric resolution platforms for the challenging spectra of ipratropium and fenoterol in their combination inhaler with ecological friendliness assessment

• Published in: Scientific reports Vol. 14; no. 1; pp. 22406 - 16
• Main Authors: Ali, Salma N., Saad, Samah S., Fayed, Ahmed S., Marzouk, Hoda M.
• Format: Journal Article
• Language: English
• Published: London Nature Publishing Group UK 28.09.2024; Nature Publishing Group; Nature Portfolio
• Subjects: 639/638/11; 639/638/224; Absorption; Administration, Inhalation; Asthma - drug therapy; Chronic obstructive pulmonary disease; Delivered dose uniformity; Drug Combinations; Drug solvents; Fenoterol; Fenoterol - administration & dosage; Fenoterol - analysis; Fenoterol - chemistry; Green and white analytical chemistry; Humanities and Social Sciences; Humans; Inhalers; Ipratropium; Ipratropium - administration & dosage; Ipratropium - analysis; Lung diseases; Mathematics; multidisciplinary; Nebulizers and Vaporizers; Pulmonary Disease, Chronic Obstructive - drug therapy; Respiration; Respiratory tract; Respiratory tract diseases; Science; Science (multidisciplinary); Spectrophotometry; Spectrophotometry - methods; Fenoterol; Chronic obstructive pulmonary disease; Delivered dose uniformity; Ipratropium; Spectrophotometry; Green and white analytical chemistry
• ISSN: 2045-2322; 2045-2322
• DOI: 10.1038/s41598-024-72431-x

Asthma and chronic obstructive pulmonary disease (COPD) are the most common diagnoses for adults and children with respiratory tract inflammation. Recently, a novel fixed dose combination consisting of Ipratropium and Fenoterol has been released for the management and control of the symptoms of such disorders. The current research has newly developed and optimized three smart, accurate, simple, cost-effective, and eco-friendly spectrophotometric methods that enabled the simultaneous determination of the drugs under study in their combined inhaler dosage form, without the need for any previous separation steps, using water as a green solvent. The strategy employed was based on calculating one or two factors as a numerical spectrum or constant, which provided the complete removal of any component in the mixture that might overlap and the mathematical filtration of the targeted analyte. The methods developed could be classified into two types of spectrophotometric windows. Window I; involved absorption spectrum in their original zero-order forms (°D), which included recently designed methods named induced concentration subtraction (ICS) and induced dual wavelength (IDW). While window III focused on the ratio spectrum as the induced amplitude modulation (IAM) method. The extremely low absorptivity and lack of distinct absorption maximum in the zero-order absorption spectrum of Ipratropium were two intrinsic challenges that were better overcome by the proposed spectrophotometric methods than by the conventionally used ones. According to ICH guidelines, the proposed methods were validated using unified regression over range 2.0–40.0 µg/mL in the ICS method, while the linearity ranges for the IDW and IAM methods were 5.0–40.0 µg/mL of Ipratropium and 2.0–40.0 µg/mL of Fenoterol. Moreover, the three proposed methods were effectively used to assay the co-formulated marketed inhaler and further expanded to confirm the delivered dose uniformity in compliance with the USP guidelines. Finally, the established methods were evaluated for their greenness and blueness, in comparison to the official and reported analysis methods, using advanced cutting edge software metrics. Furthermore, the suggested techniques adhered well to the white analytical chemistry postulates that were recently published.